NO990896L - Bidentate metalloproteaseinhibitorer - Google Patents

Bidentate metalloproteaseinhibitorer

Info

Publication number
NO990896L
NO990896L NO990896A NO990896A NO990896L NO 990896 L NO990896 L NO 990896L NO 990896 A NO990896 A NO 990896A NO 990896 A NO990896 A NO 990896A NO 990896 L NO990896 L NO 990896L
Authority
NO
Norway
Prior art keywords
bidentate
compounds
metalloprotease inhibitors
pharmaceutical compositions
inhibitors
Prior art date
Application number
NO990896A
Other languages
English (en)
Norwegian (no)
Other versions
NO990896D0 (no
Inventor
Neil Gregory Almstead
Biswanath De
Rimmi Sandler Bradley
Garry Steven Garrett
Ii John Emory Marlin
John Mcmillan Mciver
Zhe Wang
Yetunde Olabisi Taiwo
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO990896D0 publication Critical patent/NO990896D0/no
Publication of NO990896L publication Critical patent/NO990896L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Pyrrole Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO990896A 1996-08-28 1999-02-25 Bidentate metalloproteaseinhibitorer NO990896L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2474696P 1996-08-28 1996-08-28
PCT/US1997/014554 WO1998008814A1 (fr) 1996-08-28 1997-08-22 Inhibiteurs de metalloproteases bidentees

Publications (2)

Publication Number Publication Date
NO990896D0 NO990896D0 (no) 1999-02-25
NO990896L true NO990896L (no) 1999-04-20

Family

ID=21822181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990896A NO990896L (no) 1996-08-28 1999-02-25 Bidentate metalloproteaseinhibitorer

Country Status (20)

Country Link
US (1) US6121272A (fr)
EP (1) EP0923547A1 (fr)
JP (1) JP2000516954A (fr)
KR (1) KR20000035921A (fr)
CN (1) CN1228767A (fr)
AU (1) AU4074097A (fr)
BR (1) BR9712792A (fr)
CA (1) CA2263914A1 (fr)
CO (1) CO5420196A1 (fr)
CZ (1) CZ62499A3 (fr)
HU (1) HUP0000616A2 (fr)
ID (1) ID18417A (fr)
IL (1) IL128665A0 (fr)
NO (1) NO990896L (fr)
PE (1) PE109298A1 (fr)
PL (1) PL331803A1 (fr)
SK (1) SK24899A3 (fr)
TR (1) TR199900401T2 (fr)
WO (1) WO1998008814A1 (fr)
ZA (1) ZA977697B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0004595A3 (en) 1997-07-31 2001-12-28 Procter & Gamble Acyclic metalloprotease inhibitors
EP1918278A1 (fr) 1998-02-04 2008-05-07 Novartis AG Dérivés de sulfonylamino qui inhibent les métalloprotéases à dégradation de matrice
US6410580B1 (en) 1998-02-04 2002-06-25 Novartis Ag Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
PL348661A1 (en) 1998-06-03 2002-06-03 Gpi Nil Holdings N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
EP1132379A4 (fr) 1998-09-21 2005-02-16 Takeda Pharmaceutical Nouveaux derives de thiol, leur procede de production et leur utilisation
US6566381B1 (en) 1999-03-03 2003-05-20 The Procter & Gamble Company Hetero-substituted metalloprotease inhibitors
IL145089A0 (en) 1999-03-03 2002-06-30 Procter & Gamble Alkenyl-and alkynyl-containing metalloprotease inhibitors
AU6499000A (en) * 1999-08-05 2001-03-05 Procter & Gamble Company, The Multivalent compounds
AU6388500A (en) * 1999-08-05 2001-03-05 Procter & Gamble Company, The Multivalent sulfonamides
CA2415065C (fr) 2000-06-30 2009-09-15 The Procter & Gamble Company Compositions orales comprenant un agent de modulation de la reponse d'hotes
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
BR0112656A (pt) 2000-07-19 2003-06-24 Hoffmann La Roche Compostos, composições farmacêuticas que contêm os mesmos, utilização desses compostos,: processo para tratamento terapêutico e/ou profilático e processo para a preparação desses compostos
EP1303485A1 (fr) * 2000-07-19 2003-04-23 F. Hoffmann-La Roche Ag Derives de pyrrolidine utilises comme inhibiteurs de l'enzyme de conversion de l'endotheline
JP3983663B2 (ja) * 2000-07-19 2007-09-26 エフ．ホフマン−ラ ロシュ アーゲー メタロプロテアーゼインヒビターとしてのピロリジン誘導体
FR2819252A1 (fr) * 2001-01-11 2002-07-12 Servier Lab Nouveaux derives d'acide hydroxamique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2449019A1 (fr) * 2001-05-29 2002-12-05 Guilford Pharmaceuticals Inc. Procede de traitement d'accidents nerveux entraines par une operation
WO2004056766A1 (fr) * 2002-12-19 2004-07-08 Vertex Pharmaceuticals Incorporated Inhibiteurs d'enzyme tace
WO2008130718A1 (fr) 2007-04-23 2008-10-30 Atherogenics, Inc. Composés contenant du sulfonamide pour le traitement de troubles inflammatoires
CN106905183B (zh) * 2017-02-24 2018-07-31 三峡大学 一类含氨基的ɑ-酰氧基羰基酰胺类衍生物，制备方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501489A (en) * 1966-01-21 1970-03-17 American Home Prod 1-phenylsulfonyl-2-(2-thiazolin-2-yl-oxy and thiol) pyrrolidines
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
IL74140A (en) * 1984-04-10 1988-05-31 Robins Co Inc A H Substituted n-((amino)alkyl)-1-pyrrolidine,-1-piperidine and-1-homopiperidine-carboxamides and pharmaceutical compositions containing them
US4595700A (en) * 1984-12-21 1986-06-17 G. D. Searle & Co. Thiol based collagenase inhibitors
GB8515934D0 (en) * 1985-06-24 1985-07-24 Janssen Pharmaceutica Nv (4-piperidinomethyl and-hetero)purines
IT1215590B (it) * 1987-06-29 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzene solfonil 2-oco 5-alchiltio pirrolidina, un loro procedimentodi preparazione e il loro impiegocome stostanze medicinali.
GB8814813D0 (en) * 1988-06-22 1988-07-27 Beecham Group Plc Novel compounds
DE4011172A1 (de) * 1990-04-06 1991-10-10 Degussa Verbindungen zur bekaempfung von pflanzenkrankheiten
US5244908A (en) * 1990-07-30 1993-09-14 Takeda Chemical Industries, Ltd. Imidazopyridine derivatives and their pharmaceutical use
JPH05125029A (ja) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアミド化合物又はその塩
US6090785A (en) * 1992-10-15 2000-07-18 Merck & Co., Inc. Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative agents
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5470834A (en) * 1993-10-06 1995-11-28 Florida State University Sulfoximine and suldodiimine matrix metalloproteinase inhibitors
US5455262A (en) * 1993-10-06 1995-10-03 Florida State University Mercaptosulfide metalloproteinase inhibitors
GB2303850B (en) * 1994-06-22 1998-06-10 British Biotech Pharm Metalloproteinase inhibitors
ES2196163T3 (es) * 1995-07-31 2003-12-16 Shionogi & Co Derivados de pirrolidina con una actividad de inhibicion de la fosfolipasa a2.
AU725831C (en) * 1995-12-08 2002-10-17 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation

Also Published As

Publication number Publication date
NO990896D0 (no) 1999-02-25
ID18417A (id) 1998-04-09
JP2000516954A (ja) 2000-12-19
IL128665A0 (en) 2000-01-31
TR199900401T2 (xx) 1999-05-21
EP0923547A1 (fr) 1999-06-23
SK24899A3 (en) 2000-04-10
PL331803A1 (en) 1999-08-02
KR20000035921A (ko) 2000-06-26
AU4074097A (en) 1998-03-19
ZA977697B (en) 1998-02-23
US6121272A (en) 2000-09-19
WO1998008814A1 (fr) 1998-03-05
BR9712792A (pt) 1999-12-14
HUP0000616A2 (en) 2000-07-28
CA2263914A1 (fr) 1998-03-05
CZ62499A3 (cs) 1999-07-14
CN1228767A (zh) 1999-09-15
PE109298A1 (es) 1999-01-31
CO5420196A1 (es) 2004-07-30

Similar Documents

Publication Publication Date Title
NO990896L (no) Bidentate metalloproteaseinhibitorer
PL331802A1 (en) Substituted cyclic amines as metaloprotease inhibitors
CA2264254A1 (fr) Amides d'acide phosphinique utilises comme inhibiteurs de metalloproteases de matrices
NO20024521L (no) Heterocyklisk sidekjede-inneholdende metalloproteaseinhibitorer
NO990760L (no) 1,4-heterocykliske metallproteaseinhibitorer
WO1999006340A3 (fr) Inhibiteurs de metalloprotease acycliques
BR9909620A (pt) Inibidores de metaloproteases de hidroxamato de pirrolidina substituìdo
CA2367017A1 (fr) Inhibiteurs de l'enzyme impdh
WO2003024448A3 (fr) Inhibiteurs de l'histone-deacetylase
FI942423A (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
AU6894800A (en) Caspase inhibitors and uses thereof
WO2000051993A3 (fr) Inhibiteurs de metalloproteases dihetero-substitues
BR0008716A (pt) Inibidores de metaloprotease contendo alquenil ou alquinil
NO984740L (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
BR0109328A (pt) Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica
EA199900057A1 (ru) Ингибиторы матриксных металлопротеиназ
CA2266759A1 (fr) Derives 3-mercaptoacetylamino-1,5-substitue-2-oxo-azepane, utilises comme inhibiteurs de metalloproteinase matrice
WO2001070720A3 (fr) Chaine laterale carbocyclique contenant des inhibiteurs de metalloprotease n-substitues
NO20014241L (no) C16-umettede FP-selektive prostaglandinanaloger
WO2001070693A3 (fr) Inhibiteurs de metalloproteases d'acide difluorobutyrique
BR0014759A (pt) Inibidores de metaloprotease beta dissubstituìdos
NO20011038L (no) Substituerte dihydrobenzopyraner nyttige som antiarytmiske midler
ATE271384T1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
WO2001070682A3 (fr) Chaine laterale carbocyclique contenant des inhibiteurs de metalloproteases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application